Gastrointestinal stromal tumor: Analysis of outcome and correlation with c-kit status in Indian population

被引:6
作者
Cyriac, S. [1 ]
Rajendranath, R. [2 ]
Sagar, T. G. [2 ]
机构
[1] Caritas Canc Inst, Kottayam, Kerala, India
[2] Canc Inst WIA, Dept Med Oncol, Madras, Tamil Nadu, India
关键词
Gastrointestinal stromal tumor; Imatinib; c-kit; IMATINIB MESYLATE; KINASE MUTATIONS; TYROSINE KINASE; EFFICACY; GIST;
D O I
10.4103/0019-509X.134616
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aims: The aim of the present study is to analyse the outcome and genotypic pattern of metastatic GIST patients which is largely unknown in India. Materials and Methods: The present study was a retrospective analysis of 24 patients of metastatic GIST. The case records were analysed for clinical profile, treatment response and prognostic factors. The archival samples were retrieved for c-kit mutation analysis in all but 5 patients for mutation analysis. Results: The median age of the study population was 56 years. At a median follow up of 29 months, the PFS was 45% at 2 years. Activating c-kit mutations were detected in 10 cases (52.6%). 80% of the mutations were located in Exon 11. Conclusions: The outcome of metastatic GIST patients has definitely improved from a virtually incurable state to a disease where median OS has reached 60 months. The genotype of Indian patients with GIST may be different from the western population which needs to be confirmed in a larger study.
引用
收藏
页码:35 / 39
页数:5
相关论文
共 14 条
[1]   Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033 [J].
Blanke, Charles D. ;
Rankin, Cathryn ;
Demetri, George D. ;
Ryan, Christopher W. ;
von Mehren, Margaret ;
Benjamin, Robert S. ;
Raymond, A. Kevin ;
Bramwell, Vivien H. C. ;
Baker, Laurence H. ;
Maki, Robert G. ;
Tanaka, Michael ;
Hecht, J. Randolph ;
Heinrich, Michael C. ;
Fletcher, Christopher D. M. ;
Crowley, John J. ;
Borden, Ernest C. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (04) :626-632
[2]   Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors [J].
Demetri, GD ;
von Mehren, M ;
Blanke, CD ;
Van den Abbeele, AD ;
Eisenberg, B ;
Roberts, PJ ;
Heinrich, MC ;
Tuveson, DA ;
Singer, S ;
Janicek, M ;
Fletcher, JA ;
Silverman, SG ;
Silberman, SL ;
Capdeville, R ;
Kiese, B ;
Peng, B ;
Dimitrijevic, S ;
Druker, BJ ;
Corless, C ;
Fletcher, CDM ;
Joensuu, H .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (07) :472-480
[3]  
Demetri GD, 2005, CANC PRINCIPLES PRAC, P1050
[4]   Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells [J].
Druker, BJ ;
Tamura, S ;
Buchdunger, E ;
Ohno, S ;
Segal, GM ;
Fanning, S ;
Zimmermann, J ;
Lydon, NB .
NATURE MEDICINE, 1996, 2 (05) :561-566
[5]  
Eva W, 2003, INT J CANCER, V106, P887
[6]   Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor [J].
Heinrich, MC ;
Corless, CL ;
Demetri, GD ;
Blanke, CD ;
von Mehren, M ;
Joensuu, H ;
McGreevey, LS ;
Chen, CJ ;
Van den Abbeele, AD ;
Druker, BJ ;
Kiese, B ;
Eisenberg, B ;
Roberts, PJ ;
Singer, S ;
Fletcher, CDM ;
Silberman, S ;
Dimitrijevic, S ;
Fletcher, JA .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (23) :4342-4349
[7]   Kinase Mutations and Efficacy of Imatinib in Korean Patients with Advanced Gastrointestinal Stromal Tumors [J].
Kim, Tae Won ;
Ryu, Min-Hee ;
Lee, Heungnam ;
Sym, Sun Jin ;
Lee, Jae-Lyun ;
Chang, Heung Moon ;
Park, Young Suk ;
Lee, Kyung Hee ;
Kang, Won Ki ;
Shin, Dong Bok ;
Bang, Yung-Jue ;
Lee, Jung Shin ;
Kang, Yoon-Koo .
ONCOLOGIST, 2009, 14 (05) :540-547
[8]   Clinical significance of oncogenic KIT and PDGFRA mutations in gastrointestinal stromal tumours [J].
Lasota, J. ;
Miettinen, M. .
HISTOPATHOLOGY, 2008, 53 (03) :245-266
[9]   KIT extracellular and kinase domain mutations in gastrointestinal stromal tumors [J].
Lux, ML ;
Rubin, BP ;
Biase, TL ;
Chen, CJ ;
Maclure, T ;
Demetri, G ;
Xiao, S ;
Singer, S ;
Fletcher, CDM ;
Fletcher, JA .
AMERICAN JOURNAL OF PATHOLOGY, 2000, 156 (03) :791-795
[10]  
Rubin BP, 2001, CANCER RES, V61, P8118